The Patent Finder

Capstone Therapeutics Corp.

Also on record
Records under this name other than patents Capstone Therapeutics Corp. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Capstone Therapeutics Corp.

PatentTitleStatus Expires Confidence
US 8,334,259Method of Treating Endothelial Dysfunction Comprising Administration of a Thrombin Peptide Derivative
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,952,129Method of treating degenerative diseases
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,833,982Methods of Treating Dermal Ulcers with Thrombin Derived Peptides
Formerly held
Term ended
Ended no later than Jul 18, 2022 · Low confidence
Term endedEnded no later than Jul 18, 2022Low confidence
US 6,867,190Methods of Therapy with Thrombin Derived Peptides
Formerly held
Term ended
Ended no later than Jun 29, 2022 · Medium confidence
Term endedEnded no later than Jun 29, 2022Medium confidence
US 7,049,294Use of Thrombin-Derived Peptides for the Therapy of Chronic Dermal Ulcers
Formerly held
Term ended
Term ended Jan 16, 2022 · High confidence
Term endedTerm ended Jan 16, 2022High confidence
US 7,378,500Use of thrombin-derived peptides for the therapy of chronic dermal ulcers
Formerly held
Term ended
Ended no later than Jan 16, 2022 · From the USPTO record
Term endedEnded no later than Jan 16, 2022From the USPTO record
US 6,914,050Stimulation of Bone Growth with Thrombin Peptide Derivatives
Formerly held
Term ended
Term ended Sep 29, 2021 · High confidence
Term endedTerm ended Sep 29, 2021High confidence
US 6,894,027Stimulation of Bone Growth with Thrombin Peptide Derivatives
Formerly held
Lapsed on the fee record
Ended May 17, 2017 · High confidence
Lapsed on the fee recordEnded May 17, 2017High confidence
US 6,855,687Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor
Formerly held
Lapsed on the fee record
Ended Feb 15, 2017 · From the USPTO record
Lapsed on the fee recordEnded Feb 15, 2017From the USPTO record
US 6,815,416Stimulation of Cartilage Growth with Agonists of the Non-Proteolytically Activated Thrombin Receptor
Formerly held
Lapsed on the fee record
Ended Nov 9, 2016 · Medium confidence
Lapsed on the fee recordEnded Nov 9, 2016Medium confidence
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited